About: Speaker abstracts

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Speaker abstracts Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Speaker abstracts
Creator	Johnston, Stephen Chen, Wendy Norton, Larry Gianni, Luca Hortobagyi, Gabriel Suter, Thomas
Source	PMC
abstract	covid:e6c2ccc70741ad540f89382996e4753912e81f68#abstract
has issue date	2011-02-15(xsd:dateTime)
bibo:doi	10.1002/ijc.25875
has license	no-cc
sha1sum (hex)	e6c2ccc70741ad540f89382996e4753912e81f68
schema:url	https://doi.org/10.1002/ijc.25875
resource representing a document's title	Speaker abstracts
has PubMed Central identifier	PMC7165546
schema:publication	Int J Cancer
resource representing a document's body	covid:e6c2ccc70741ad540f89382996e4753912e81f68#body_text
is schema:about of	named entity 'integrating' named entity 'studies' named entity 'anthracyclines' named entity 'breast cancer' named entity 'remain' covid:arg/e6c2ccc70741ad540f89382996e4753912e81f68 named entity 'validated' named entity 'Design' named entity 'anthracyclines' named entity 'sensitivity' named entity 'deletion' named entity 'taxanes' named entity 'adjuvant treatment' named entity 'taxanes' named entity 'adjuvant treatment' named entity 'breast cancer' named entity 'breast cancer' named entity 'adjuvant' named entity 'France' named entity 'England and Wales' named entity 'biomarkers' named entity 'APC' named entity 'breast cancer' named entity 'TNM' named entity 'emetogenic' named entity 'AJCC' named entity 'RRM1' named entity 'EGFR' named entity 'HPV' named entity 'ovary' named entity 'lung cancer' named entity 'oncology' named entity 'promoter methylation' named entity 'oncologists' named entity '3.8' named entity 'AJCC' named entity 'IGF1R' named entity 'immunosuppressed' named entity 'RSV' named entity 'phase III trial' named entity 'fos' named entity 'treatment of cancer' named entity 'randomized clinical trials' named entity 'antiangiogenic' named entity 'primary tumors' named entity 'NICE' named entity 'statistically significant' named entity 'radiation damage' named entity 'second-line' named entity 'metastatic disease' named entity 'NSCLC' named entity 'life expectancy' named entity 'cisplatinum' named entity 'laser ablation' named entity 'osseous' named entity 'opioids' named entity 'peritoneal carcinomatosis' named entity 'cancer drugs' named entity 'combination therapies' named entity 'post-operative' named entity 'magnetic resonance imaging' named entity 'clinical trials' named entity 'EBRT' named entity 'taxane' named entity 'PSA' named entity 'clinical research' named entity 'cancer staging' named entity 'IFNa' named entity 'Rituximab' named entity 'based on evidence' named entity 'INK4a' named entity 'immunotherapy' named entity 'vaccination' named entity 'metastasectomy' named entity 'Overdiagnosis' named entity 'lung cancer' named entity 'number needed to treat' named entity 'broad spectrum'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software